Analyst Ratings for [FTRE] Fortrea Holdings Inc.

8/4/25	Upgrades	Neutral Outperform	X
FTRE Fortrea Robert W. Baird
$9
5/2/25	Initiated	Hold	X
FTRE Fortrea Truist
$7
4/10/25	Downgrades	Eq Weight Underweight	X
FTRE Fortrea Barclays
$6
12/11/24	Downgrades	Buy Neutral	X
FTRE Fortrea Citigroup
$30 $23
12/6/24	Downgrades	Outperform Neutral	X
FTRE Fortrea Robert W. Baird
$28 $25
9/25/24	Downgrades	Buy Hold	X
FTRE Fortrea Jefferies
$25 $21
8/8/24	Downgrades	Outperform In-line	X
FTRE Fortrea Evercore ISI
$31 $27
7/24/24	Resumed	Equal Weight	X
FTRE Fortrea Barclays
$30
6/6/24	Initiated	Neutral	X
FTRE Fortrea Goldman
$28
5/29/24	Initiated	Hold	X
FTRE Fortrea TD Cowen
$27
5/28/24	Initiated	Neutral	X
FTRE Fortrea Mizuho
$27
3/22/24	Initiated	Neutral	X
FTRE Fortrea Robert W. Baird
$43
3/6/24	Initiated	Hold	X
FTRE Fortrea Deutsche Bank
$36
1/5/24	Initiated	Mkt Perform	X
FTRE Fortrea William Blair
1/4/24	Initiated	Buy	X
FTRE Fortrea Jefferies
$44
12/11/23	Upgrades	Neutral Buy	X
FTRE Fortrea Citigroup
$34 $40
12/1/23	Upgrades	In-line Outperform	X
FTRE Fortrea Evercore ISI
$32 $36
11/14/23	Upgrades	Eq Weight Overweight	X
FTRE Fortrea Barclays
$29 $38
10/19/23	Initiated	Neutral	X
FTRE Fortrea Citigroup
$32
9/14/23	Initiated	In-line	X
FTRE Fortrea Evercore ISI
$31
8/16/23	Initiated	Equal Weight	X
FTRE Fortrea Barclays
$29
8/7/23	Initiated	Underperform	X
FTRE Fortrea BofA Securities
$27

FTRE Fortrea Holdings Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina.